SCM
PRME icon

Sterling Capital Management’s Prime Medicine PRME Stock Holding History

Sterling Capital Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.98K Sell
536
-2,926
-85% -$9.72K ﹤0.01% 2995
2026
Q1 		$12K Sell
3,462
-2,274
-40% -$8.65K ﹤0.01% 2277
2025
Q4 		$19.9K Buy
5,736
+542
+10% +$2.41K ﹤0.01% 2230
2025
Q3 		$28.8K Buy
5,194
+3,618
+230% +$14.7K ﹤0.01% 1978
2025
Q2 		$3.89K Buy
1,576
+1,518
+2,617% +$2.34K ﹤0.01% 2649
2025
Q1 		$115 Hold
58
– – ﹤0.01% 3132
2024
Q4 		$169 Hold
58
– – ﹤0.01% 3133
2024
Q3 		$224 Buy
+58
New +$269 ﹤0.01% 3098

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Sterling Capital Management's PRME Position: Q2 2026 in Review

Sterling Capital Management reduced its Prime Medicine (PRME) stake by 85% in Q2 2026, selling an estimated $9.72K and leaving 536 shares worth $1.98K. The position accounts for ﹤0.01% of the portfolio, ranked #2995.

Sterling Capital Management first reported a position in PRME in Q3 2024 and has held it in 8 quarters since. The position peaked at $28.8K in Q3 2025. 188 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Sterling Capital Management held 536 shares of Prime Medicine worth $1.98K as of Q2 2026.
  • Sterling Capital Management sold 2,926 Prime Medicine shares in Q2 2026, an estimated $9.72K.
  • Prime Medicine made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2995 holding.
  • Sterling Capital Management first reported a position in Prime Medicine in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Prime Medicine position peaked at $28.8K in Q3 2025.
  • 188 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.